Pharminox appoints Dr Marc Hummersone to its Board of Directors
The Company also announced that Professor Malcolm Stevens OBE, FRS is standing down from the Board and as Chief Scientific Officer and will take up the honorary position of CSO Emeritus.
In his new role, Dr Hummersone will take over full responsibility for discovery research operations and strategy within Pharminox. Professor Stevens will continue to provide input and support on all aspects of discovery research in his capacity as CSO Emeritus.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.